The Cooper Companies, Inc. (NASDAQ:COO) Stock Position Trimmed by Blair William & Co. IL

Key Points

• Blair William & Co. IL has reduced its stake in The Cooper Companies, Inc. by 10.9%, now holding 35,059 shares valued at approximately $2.96 million.
• The Cooper Companies reported $1 billion in revenue and $0.96 EPS for the recent quarter, exceeding expectations and indicating a 6.3% year-over-year revenue growth.
• Analyst ratings have been adjusted, with Piper Sandler lowering their price target from $115.00 to $105.00, while Wells Fargo cut their target from $118.00 to $93.00.

Blair William & Co. IL decreased its position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 10.9% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 35,059 shares of the medical device company's stock after selling 4,278 shares during the period. Blair William & Co. IL's holdings in Cooper Companies were worth $2,957,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in the company. Mirae Asset Global Investments Co. Ltd. grew its position in Cooper Companies by 15.1% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 26,189 shares of the medical device company's stock valued at $2,194,000 after buying an additional 3,440 shares in the last quarter. DAVENPORT & Co LLC lifted its stake in shares of Cooper Companies by 13.4% in the 1st quarter. DAVENPORT & Co LLC now owns 4,335 shares of the medical device company's stock worth $366,000 after acquiring an additional 513 shares during the period. Cerity Partners LLC boosted its holdings in shares of Cooper Companies by 6.6% in the first quarter. Cerity Partners LLC now owns 17,113 shares of the medical device company's stock valued at $1,443,000 after acquiring an additional 1,054 shares in the last quarter. State of Alaska Department of Revenue boosted its holdings in shares of Cooper Companies by 3.0% in the first quarter. State of Alaska Department of Revenue now owns 23,390 shares of the medical device company's stock valued at $1,972,000 after acquiring an additional 680 shares in the last quarter. Finally, Cetera Investment Advisers increased its stake in shares of Cooper Companies by 1.3% during the fourth quarter. Cetera Investment Advisers now owns 24,049 shares of the medical device company's stock valued at $2,211,000 after acquiring an additional 312 shares during the period. Institutional investors and hedge funds own 24.39% of the company's stock.

Cooper Companies Stock Up 1.6%

Shares of NASDAQ:COO opened at $69.20 on Friday. The firm has a 50 day simple moving average of $71.50 and a 200 day simple moving average of $80.12. The Cooper Companies, Inc. has a 52 week low of $65.00 and a 52 week high of $112.38. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.23 and a current ratio of 2.10. The company has a market cap of $13.84 billion, a PE ratio of 33.59, a price-to-earnings-growth ratio of 1.66 and a beta of 1.00.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its earnings results on Thursday, May 29th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.93 by $0.03. The company had revenue of $1 billion for the quarter, compared to the consensus estimate of $995.12 million. Cooper Companies had a net margin of 10.39% and a return on equity of 9.60%. The company's revenue was up 6.3% on a year-over-year basis. During the same period in the previous year, the business earned $0.85 EPS. As a group, research analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Analyst Ratings Changes

A number of equities analysts have issued reports on COO shares. Piper Sandler reaffirmed an "overweight" rating and set a $105.00 price target (down from $115.00) on shares of Cooper Companies in a research note on Friday, May 30th. JPMorgan Chase & Co. reaffirmed a "neutral" rating and set a $76.00 target price (down previously from $110.00) on shares of Cooper Companies in a research note on Friday, May 30th. Robert W. Baird dropped their price target on shares of Cooper Companies from $107.00 to $97.00 and set an "outperform" rating on the stock in a research report on Friday, May 30th. Wells Fargo & Company reduced their price objective on shares of Cooper Companies from $118.00 to $93.00 and set an "overweight" rating for the company in a research report on Friday, May 30th. Finally, Wall Street Zen cut shares of Cooper Companies from a "buy" rating to a "hold" rating in a research note on Saturday, July 12th. Three investment analysts have rated the stock with a hold rating, nine have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $96.73.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.